Medicare Reviewing Potential Coverage of Genetic Tests | GenomeWeb

NEW YORK (GenomeWeb News) – The Center for Medicare Services is beginning to take a closer look at genetic tests and will consider if some of these molecular tests should be approved for coverage under the program.

CMS will review evidence on genetic tests, assess their preventive value, and will consider gene expression and pharmagoconemic tests for coverage decisions, according to CMS's Chief Medical Officer, Barry Straube, who spoke recently at a Department of Health and Human Services meeting in Washington, DC.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.